Tag: daxibotulinumtoxina

All

Revance Reports Q4 and Full Year 2021 Financial Results; Credits Dermal Filler Sales for Growth

The company also announced progress on its DaxibotulinumtoxinA for Injection for glabellar lines and intent to launch the RHA Redensity dermal filler in the second half of 2022.

Revance Resubmits BLA to FDA for DaxibotulinumtoxinA for Injection
Aesthetic Surgeon Shares Insights on DAXI’s Potential
Letybo, a Botulinum Toxin Recently Approved in US, Expands to Malaysia

All

Sorry, No Posts Found

All

China Releases First Evidence-Based Guidelines for Laser and Aesthetic Medicine

The new standards provide treatment recommendations for 26 common conditions for practitioners treating Asian skin types.

Cartessa Aesthetics Launches Onda Pro for Noninvasive Body Contouring in US and Canada
Empowering Plastic Surgery Practices with Better Financing Technology for Operational Excellence and Access to Care
New Index Ranks Which Aesthetic Brands Show Up in AI Search

Tag: daxibotulinumtoxina

All

Revance Reports Q4 and Full Year 2021 Financial Results; Credits Dermal Filler Sales for Growth

Revance Resubmits BLA to FDA for DaxibotulinumtoxinA for Injection

Aesthetic Surgeon Shares Insights on DAXI’s Potential

Letybo, a Botulinum Toxin Recently Approved in US, Expands to Malaysia

All

Sorry, No Posts Found

All

China Releases First Evidence-Based Guidelines for Laser and Aesthetic Medicine

Cartessa Aesthetics Launches Onda Pro for Noninvasive Body Contouring in US and Canada

Empowering Plastic Surgery Practices with Better Financing Technology for Operational Excellence and Access to Care

New Index Ranks Which Aesthetic Brands Show Up in AI Search

Sorry, No Posts Found

Plastic Surgery Practice

Our Parent Company

Key Resources

Helpful Links